HLA and Killer Cell Immunoglobulin-like Receptors Influence the Natural Course of CMV Infection

• Published in: The Journal of infectious diseases Vol. 210; no. 7; pp. 1083 - 1089
• Main Authors: Di Bona, Danilo, Scafidi, Valeria, Plaia, Antonella, Colomba, Claudia, Nuzzo, Domenico, Occhino, Cecilia, Tuttolomondo, Antonino, Giammanco, Giovanni, De Grazia, Simona, Montalto, Giuseppe, Duro, Giovanni, Cippitelli, Marco, Caruso, Calogero
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 01.10.2014
• Subjects: Adolescent; Adult; Aged; Alleles; Cytomegalovirus; Cytomegalovirus - immunology; Cytomegalovirus Infections - immunology; Cytomegalovirus Infections - pathology; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Histocompatibility Antigens Class I - genetics; Histocompatibility Antigens Class I - immunology; Histocompatibility Antigens Class I - metabolism; HIV infections; HLA antigens; Human cytomegalovirus; Humans; Infections; Ligands; Male; Middle Aged; Natural killer cells; Receptors; Receptors, KIR - genetics; Receptors, KIR - immunology; Receptors, KIR - metabolism; Statistical significance; VIRUSES; Young Adult; cytomegalovirus; HLA; KIR
• ISSN: 0022-1899; 1537-6613; 1537-6613
• DOI: 10.1093/infdis/jiu226

Background. Natural killer (NK) cells provide a major defense against cytomegalovirus (CMV) infection through the interaction of their surface receptors, including the activating and inhibitory killer immunoglobulinlike receptors (KIRs), and human leukocyte antigens (HLA) class I molecules. This study assessed whether the KIR and HLA repertoire may influence the risk of developing symptomatic or asymptomatic disease after primary CMV infection in the immunocompetent host. Methods. Sixty immunocompetent patients with primary symptomatic CMV infection were genotyped for KIR and their HLA ligands, along with 60 subjects with a previous asymptomatic infection as controls. Results. The frequency of the homozygous A haplotype (only KIR2DS4 as activating KIR) was higher in symptomatic patients than controls (30% vs 12%, respectively; odds ratio [OR] = 3.24; P = .01). By logistic regression, the risk of developing symptomatic disease was associated with the homozygous A haplotype and the HLABw4T allele. Combining the 2 independent variables, we found that 37 out of 60 (62%) symptomatic patients but only 18 out of 60 (30%) of controls possessed the homozygous A haplotype or the HLABw4T allele with a highly significant OR (OR = 3.75, P<.0005). Conclusions. Immunocompetent subjects carrying the homozygous A haplotype or the HLABw4T allele are at higher risk of developing symptomatic disease after primary CMV infection.